Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Convertible Debt (2023 - 2025)

Historic Convertible Debt for TransMedics (TMDX) over the last 3 years, with Q3 2025 value amounting to $452.1 million.

  • TransMedics' Convertible Debt rose 63.33% to $452.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.1 million, marking a year-over-year increase of 63.33%. This contributed to the annual value of $449.9 million for FY2024, which is 62.6% up from last year.
  • TransMedics' Convertible Debt amounted to $452.1 million in Q3 2025, which was up 63.33% from $451.4 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Convertible Debt ranged from a high of $452.1 million in Q3 2025 and a low of $445.8 million during Q2 2023
  • Over the past 3 years, TransMedics' median Convertible Debt value was $448.9 million (recorded in 2024), while the average stood at $448.9 million.
  • Per our database at Business Quant, TransMedics' Convertible Debt soared by 61.33% in 2024 and then soared by 63.33% in 2025.
  • Quarter analysis of 3 years shows TransMedics' Convertible Debt stood at $447.1 million in 2023, then grew by 0.63% to $449.9 million in 2024, then grew by 0.48% to $452.1 million in 2025.
  • Its last three reported values are $452.1 million in Q3 2025, $451.4 million for Q2 2025, and $450.6 million during Q1 2025.